Skip to NavigationSkip to content

News

Boehringer Ingelheim has bought Swiss biotech AMAL Therapeutics, a company focused on cancer immunotherapy and cancer vaccines.
The FDA has recognised Slovakia’s ability to carry out inspections of manufacturing facilties.
The FDA had said it will not approve AstraZeneca’s diabetes drug Farxiga for use as a supplement to insulin in adults with Type 1 diabetes who...
British multinational GlaxoSmithKline has said ovarian cancer drug Zejula (niraparib) met its primary endpoint in a Phase 3 trial.
Gilead has entered into a 10 year partnership with Belgo-Dutch biotech Galapagos NV.
Canadian firm Generex Biotechnology has acquired Texas-based medical and surgical products distributor Medisource Partners.
AstraZeneca’s cancer immunotherapy Imfinzi has been granted orphan drug status as a treatment for small cell lung cancer (SCLC).
Senator Bernie Sanders is set to join people with Type 1 diabetes on a trip to Canada in search of cheaper insulin.
Novartis, Amgen and Banner Alzheimer's Institute have dropped a study into investigational Alzheimer’s drug CNP520 (umibecestat) after some patient...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches